BSEBoard Meeting2d ago · 13 Nov 2026, 01:36 pm
Outcome of Board Meeting held on 13th November, 2026 - Approval of Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026.
Stallion India Fluorochemicals Ltd · 544342
✦ AI SummaryResults
Stallion India Fluorochemicals Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors. The company reported a profit of ₹ 5,559 lakhs and a total comprehensive income of ₹ 5,591 lakhs. The earnings per equity share for the quarter and half year were ₹ 0.21 and ₹ 0.181 respectively. The company's paid-up equity share capital remains unchanged at ₹ 11,608.57 lakhs.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Stallion India Fluorochemicals Ltd - 544342 - Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November, 2026 - Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026.
Attachments (1)
📄pdf
Download →
9899586a-b744-4de0-a89a-bb71cc66b01f.pdf
View document text
Date: 13th November, 2026
To, To,
National Stock Exchange of India Limited BSE Limited (“BSE”),
(“NSE”), The Listing Department Corporate Relationship Department,
Exchange Plaza, 5th Floor, 2nd Floor, New Trading Ring,
Plot No. C/1, G Block, Bandra-Kurla P.J. Towers, Dalal Street,
Complex Bandra (East), Mumbai – 400 051. Mumbai – 400 001.
NSE Symbol: STALLION BSE Scrip Code: 544342
ISIN: INE0RYC01010 ISIN: INE0RYC01010
Sub: Outcome of Board Meeting held on 13th November, 2026
Dear Sir/Madam,
Pursuant to Regulations 30, 33, and other applicable provisions of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015 ("SEBI Listing Regulations"), we wish to inform you that the Board of Directors of
the Company, at its meeting held today, i.e., November 13th, 2026, which commenced at
11:30 A.M. and concluded at 01:25 PM (IST), inter alia, considered and approved the
Unaudited Financial Results of the Company for the quarter & half year ended September
30, 2025, along with the Limited Review Report issued by the Statutory Auditors.
In this regard, please find enclosed herewith Annexure I comprising the following:
A copy of the Unaudited Financial Results for the quarter & half year ended
September 30, 2026; and
The Limited Review Report issued by the Statutory Auditors of the Company.
We hereby confirmed that the Statutory Auditor has issued the Limited Review Report
on the financial results.
Yours Faithfully,
For Stallion India Fluorochemicals Limited
Govind Rao
Company Secretary & Compliance Officer
Mem No. A47094
Stallion India Fluorochemicals Limited
Registered Office :2, A Wing, Knox Plaza, Off. Link Road, Mindspace, Malad - West, Mumbai, Maharashira, India, 100064
CIN: LS1410MH2002PLC137076.
Statement of Unaudited Financial Results for the Quatter and Half Year ended September 30,2026
(@in Lakhs)
Quarter ended Thalf Year ended Near ended
P . no. — articul ars Septe ombe r30, | June30,2026 | Seple embe r3), | Seple embe r30, | Sept sembe r30, | March 31, 2036
Unaudited Unaudited Unaudited Unaudited Unaudited Audited
T [Tncome
Revenue from operations 1360315 1214060 1055641 274775 21,6060 3,06750
(Other income. 3417 e 1934 65715 271 344,50
[Total Tncome 1) 1393733 1246757 1057575 2640490 2163031 B41230
1 |Expenses
|Cost of materials consumed 1200067 738532 792584 1958999 1745186 3691024
|Changes in inventories of finished goods, Stock-in-Trade and work in-progress (2570) 167628 47955 135058 (25977) (2395.99)
Employee benefits expense 119756 2871 2489 143627 45968 94754
Finance costs ner 018 215 2085 4489 8891
Depreciation and amortization expenses 4640 %73 2949 8513 5855 1787
(Other expenses 818 1047 35870 ses.65 6183 18157
[Total expenses (1) 1336279 998870 505162 2335148 72000 3751434
T | Profit before tax (1-11) 57454 247888 152413 305342 291027 589796
IV [Taxexpense:
|C urrent tax 29028 55302 33499 84330 663,66 119135
[A djustment o tax relating to earler periods - < = . E .
Deferred tax 3897 6928 4746 10825 6861 2270
[Total tax expense (1v) 32925 6230 38245 95155, 73227 151385
V_{Profit for the period / year (II+1V) 559 155658 Tiiie7 210186 21700 [T
VI |Other ComprehensInicvomee
4.0 tems that will not be reclassified to profits or loss
Remeasurements o the defined benelit plans; 083 (18.39) 270 ©670) 1326)
(i) Income tax elating to items that will ot be reclassifed to profit or loss ©21) ey (088) 923 334
VI [Total Comprehensive Income for the period year (V+V1) Comprising Frofit and 591 T80 TI59% 210588 215053 T
Othver comprehensive Income for the peri/ yoeadr)
VIIL | Earnings per equity share
(1) Basic 021 180 142 181 273 534
2) Diluted 021 160 142 181 273 534
Paid up Eauily Share Capital ( Equity Share Capital of £10/—each 1160857 1160857 755255 L0857 753251 1160857
[Other Bquity excluding Revaluation Reserve. 59,5065 58,3075 23,00849 5950658 2385059 5645178
Net Worth 71,11515 6991833 31,027.00 711515 3178312 68,0035
Forand on behalf of the Board of
Stallion India Fluorachemicals Limited
CIN: L51410MH; 76
Shzad Rustomji
Managing Director & CEO
(DIN:01923432)
Miumbai, dated, 13th November, 2026
Stallion India Fluorochemicals Limited
Registered Office : 2, A Wing, Knox Plaza, Off. Link Road, Mindspace, Malad - West, Mumbai, Maharashtra, India, 400064
‘CIN: L51410MH2002PLC137076
Statement of Assets and Liabilities as at 30th September, 2026
(in Lakhs)
I . Asat Asat
ASSELS September 30, 2026 March 31,2026
1 [Non-current assets
(a) Property, Plant and Equipment 5,565.00 3,091.24
(b) Capital work-in-progress 9,03157 3,468.70
(c) Deferred tax assets (net) 1,004.54 1,11347
(d) Other non-current assets ~ =
2 |Current assets
() Inventories 9,71234 12,6280
(b) Tinancial Assets
(i) Trade receivables 672679 7,752.76
(if) Cash and cash equivalents 2039085 21,247.09
(iii) Bank balances other than (ii) above 8,779.09 22,119.80
(iv) Others Financial Assets 31.80 648
(<) Income tax assets (net) - -
(d) Other current assets 16,088.35 224181
[Total Assets 77,3303 73,702.16
11, [EQUITY AND LIABILITIES
EQUITY
(2) Equity Share capital 11,608.57 11,60857
(b) Other Equity 59,506.58 5645178
Total Equity 7111515 68,060.35
LIABILITIES
1 [Non-current liabilities
(a) Provisions 55.70 53.77
(b) Deferred tax liabilities (Net) 2
(<) Financial Liabilities -
(i) Lease Liabilities 606 1941
2 |Current liabilities
(a) Financial Liabilities
(i) Borrowings 616,56 3,401.14
(ii) Trade Payables
(4) total outstanding dues of micro enterprises and small -
enterprises; and
(B) total outstanding dues of creditors other than micro 4,975.02 1,814.89
enterprises and small enterprises
(iti) Lease Liabilities 2725 27.25
(b) Other current liabilities 44094 278.06
(c) Provisions 1220 1214
(d) Current Tax Liabilities (Net) 5146 3714
Total Liabilities 621519 5,643.80
[Total Equity and Liabilities 77,33034 | 73,704.16 |
For and on behalf of the Board of Directors of
Stallion India Fluorochemicals Limited
CIN: L51410MH2002PLC137076
Shazad Rustomji
Managing Director & CEO
DIN: 01923432
Mumbai, dated, 13th November, 2026
Stallion India Fluorochemicals Limited
Registered Office : 2, A Wing, Knox Plaza, Off. Link Road, Mindspace, Malad - West, Mumbai, Maharashtra, India, 400064
CIN: L51410MH2002PLC137076
Statement of Cashflow for the year ended September 30, 2026
(% in Lakhs)
et For the year ended For the year ended
September 30, 2026 September 30, 2025
"A.|Cash flows from operating activities
Profit before tax for the year 3053.02 291027
Adjustments for:
Depreciation and amortisation expenses 8513 5855
Finance costs 894 E
Interest Income on deposits (61861) (3:20)
Liabilities no longer required written back - -
Remeasurements of the defined benefit plans 270 (36.70)
Bad Debt / Advances written off - -
Allowances for doubtful debts (633) (30.02),
Bad Debt Recovered - -
ESOP Expenses 950.92 8
Gratuity Expense 469 -
Operating cash flow before working capital changes 345085 289888
Movements in working capital:
(Increase) / Decrease in trade receivables 1,03230 (196.45)
Decrease in current and non-current financial assets (2532) -
Decrease/ (Increase) in other current and non-current assets (13,846.55) 142262
I (n Dc er ce ra es ae s ei )n /i In nv ce rn et ao sr ei e is n Trade payables 32, 19 65 00. 14 36 (1, 45 889 1. 57 09)
Increase in current and non-current liabilities and provisions 160.18 1520
Cash generated from operations, (3,087.95) 3,031.97
Income taxes paid (net) (828.98) (78022)]
[Net cash generated from operating activiies (3,916.92) 225175
B.|Cash flows from investing activities
Purchase of property, plant and equipment, capital work in progress and intangible (8121.76) (86459
assets
Proceeds from disposal of property, plant and equipment - -
Investment / (Maturity) of Fixed Deposits (net) 1334071 (1,426.68)
Interest received 618.61 320
Net cash (used in)/ generated from investing activities 5,837.56 (2,266.06)
c|Cash flows from financing activities
Increase / (Decrease in Short Term Borrowings (net) (2,754.58) (127.16)
Interest pai
[Showing first 8,000 characters — download PDF for full document]